AVADEL PHARMACEUTICALS PLC — Investor Relations & Filings
Filings indexed
1,009
across all filing types
Latest filing
2024-12-10
Director's Dealing
Country
US
United States of America
Listing
US
AVDL
Avadel Pharmaceuticals PLC is a biopharmaceutical company focused on developing and commercializing therapies for sleep disorders, with a primary focus on narcolepsy. The company's lead product is LUMRYZ™, an extended-release formulation of sodium oxybate for the treatment of cataplexy or excessive daytime sleepiness in adults with narcolepsy. Avadel's core strategy involves applying innovative solutions to drug development to address the challenges and unmet needs patients face with current treatment options, aiming to disrupt existing treatment paradigms.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 4 Filing | 2024-12-10 | English | |
| 8-K Filing | 2024-12-03 | English | |
| JANUS AMENDMENT | 2024-11-14 | English | |
| AVADEL PHARMACEUTICALS PLC | 2024-11-14 | English | |
| Major Shareholding Notification 2024 | 2024-11-13 | English | |
| COWEN AND COMPANY, LLC | 2024-11-13 | English |
Browse filings by year
20 years- 2026 26 filings
- 2025 73 filings
- 2024 60 filings
- 2023 54 filings
- 2022 59 filings
- 2021 39 filings
- 2020 68 filings
- 2019 76 filings
- 2018 83 filings
- 2017 167 filings
- 2016 120 filings
- 2015 13 filings
- 2014 34 filings
- 2013 19 filings
- 2012 22 filings
- 2011 25 filings
- 2010 17 filings
- 2009 19 filings
- 2008 18 filings
- 2007 17 filings
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2024
15 filings
| |||||
| 26227122 | 4 Filing | 2024-12-10 | English | ||
| 26227043 | 8-K Filing | 2024-12-03 | English | ||
| 10714211 | JANUS AMENDMENT | 2024-11-14 | English | ||
| 10714212 | AVADEL PHARMACEUTICALS PLC | 2024-11-14 | English | ||
| 10714213 | Major Shareholding Notification 2024 | 2024-11-13 | English | ||
| 10714214 | COWEN AND COMPANY, LLC | 2024-11-13 | English | ||
| 10714217 | 10-Q | 2024-11-12 | English | ||
| 10714218 | FORM 8-K | 2024-11-12 | English | ||
| 10714219 | Major Shareholding Notification 2024 | 2024-11-08 | English | ||
| 10714221 | FORM 8-K | 2024-10-31 | English | ||
| 10714222 | Major Shareholding Notification 2024 | 2024-10-24 | English | ||
| 10714438 | FORM 8-K | 2024-10-17 | English | ||
| 10714434 | OWNERSHIP DOCUMENT | 2024-09-16 | English | ||
| 26227066 | 4 Filing | 2024-09-13 | English | ||
| 10714267 | FORM 8-K | 2024-09-12 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
AVADEL PHARMACEUTICALS PLC via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/31920/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=31920 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=31920 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=31920 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 31920}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for AVADEL PHARMACEUTICALS PLC (id: 31920)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.